BIO-key International awards contract for fingerprint biometric identity solution

NewsGuard 100/100 Score

BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions announced the award of another contract for a fingerprint biometric identity solution built on the fusion of BIO-key and MorphoTrak algorithms. The first contract for this fused solution, awarded to MorphoTrak (a Morpho company) by Lockheed Martin in September 2009, provides fingerprint identification technology for the FBI's Next Generation Identification (NGI) system. This new contract will provide large scale advanced finger matching technology to an overseas customer.

"The selection of BIO-key technology for another large-scale fingerprint identity system  is further validation of BIO-key's position as one of the premier suppliers of the industry's most accurate and scalable fingerprint matching technology," said Mike DePasquale, BIO-key's CEO. "As I predicted when we announced the first contract awarded for this fused solution, other agencies and commercial customers, looking to take advantage of the research, testing and decision by the FBI may reasonably conclude: 'If it is good enough for the FBI, it's certainly good enough for our organization.'"

Daniel Vassy, CEO of MorphoTrak, added: "We are very pleased to once again have an opportunity to deploy this fused fingerprint biometric ID solution to meet the needs for a large-scale identity program. This additional contract enhances our position as the leading provider of fingerprint identification systems, supplying law enforcement and civil identification systems to numerous local and Federal government agencies worldwide."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New machine learning model achieves breakthrough in heart disease prediction with over 95% accuracy